Session Information

Invited Symposium

[IS-TH-81] Retinoblastoma Treatment Horizons
Go back
print
Day
Apr 03 (Thu)
Time
13:30 - 15:00
Room
Room 27 - Imperial Hotel 3F Mai
Topic
Oncology
Chair/Coordinator
Chair)Akihiro Kaneko、Chair)Carol Shields、Chair)Luiz Teixeira
Description
This symposium will focus on new methods of chemotherapy for retinoblastoma. We will discuss the impact of intravenous chemotherapy, the precision of intra-arterial chemotherapy, and the horizon of intravitreal chemotherapy.

Duration 12min, Panel Discussion = Last 18min

IS-TH-81-1 / 

Oncology

Overview of Chemotherapy for Retinoblastoma: What Have We Learned?

Carol Shields

Overview of Chemotherapy for Retinoblastoma: What Have We Learned?

Duration 12min, Panel Discussion = Last 18min

IS-TH-81-2 / 

Oncology

Intravenous Chemoreduction for Eetinoblastoma: Pearls and Pitfalls

Luiz Teixeira

Intravenous Chemoreduction for Eetinoblastoma: Pearls and Pitfalls

Duration 12min, Panel Discussion = Last 18min

IS-TH-81-3 / 

Oncology

Comparison of Two Methods for Selective Ophthalmic Arterial Injections

Makoto Mohri

Comparison of Two Methods for Selective Ophthalmic Arterial Injections

Duration 12min, Panel Discussion = Last 18min

IS-TH-81-4 / 

Oncology

Management of Advanced Retinoblastoma

Santosh Honavar

Management of Advanced Retinoblastoma

Duration 12min, Panel Discussion = Last 18min

IS-TH-81-5 / 

Oncology

Intravitreal Chemotherapy for Retinoblastoma: Risks and Benefits

Francis Munier

Intravitreal Chemotherapy for Retinoblastoma: Risks and Benefits

Duration 12min, Panel Discussion = Last 18min

IS-TH-81-6 / 

Oncology

Feasibility of Vitreous Surgery for Eye Preservation Therapy of Retinoblastoma

Akihiro Kaneko

Feasibility of Vitreous Surgery for Eye Preservation Therapy of Retinoblastoma

Go back